Navigation Links
MDS Announces Agreements to Divest MDS Pharma Services' Early Stage Business
Date:2/10/2010

Technologies, MDS currently expects to initially hold between $85 million and $135 million of cash to support ongoing operations and future obligations of the Company. Beyond the estimated cash balance of between $85 million and $135 million, the Company intends to hold additional cash to fund unpaid transaction and restructuring costs associated with the sale of MDS Pharma Services and MDS Analytical Technologies. Additional details on these expected transaction and restructuring costs are available in MDS's 2009 Management's Discussion and Analysis (MD&A).

MDS's interest in the new corporation consists solely of the $25 million note and a 15% equity interest. The interest on the five-year note is 4% per annum, and the note would be repayable at the end of its five-year term or upon a future sale of the business. The note is expected to be secured by certain assets of the new corporation, which would be subordinated by the new corporation's senior credit facility.

Closing Conditions, Time Lines

The transaction is expected to close within two months, and is subject to customary approvals and closing conditions, including certain regulatory approvals and compliance with labor laws related to an operation in France.

MDS Special Committee

The Company's Special Committee of the Board of Directors, which was established in February 2009 to review strategic alternatives to improve shareholder value, is expected to be disbanded following the completion of the sale of MDS Pharma Services.

MDS Strategic Repositioning

Background materials pertaining to the new strategic direction for MDS Inc. can be found on MDS Inc.'s Website at

SOURCE MDS Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... ... software products, announced today that it has received trademark protection for its SensorInsight® ... detailed analysis of data from multiple sources providing an environment where users can ...
(Date:7/1/2015)... ... July 01, 2015 , ... Amada Senior Care, premier provider ... in the greater Phoenix area – their Mesa, Arizona location . Amada franchise ... with their purchase of the rights to the area after years of experience in ...
(Date:7/1/2015)... Bethlehem, PA (PRWEB) , ... July 01, 2015 , ... ... seek meaning and purpose in life with a healthy balance between work and life, ... do this in her new book, Positive Health: Flourishing Lives, Wellbeing in Doctors. , ...
(Date:7/1/2015)... Newport Beach, CA (PRWEB) , ... July 01, ... ... Orrick has returned to the Northbound team as Director of Referral Relations. ... two programs, including Northbound’s Collegebound, where she designed and implemented unique academic curriculum ...
(Date:7/1/2015)... ... July 01, 2015 , ... AvePoint, the ... opening of a new operational office in Zurich, Switzerland. The new facility will ... lines of business for organizations throughout the Swiss market. , “AvePoint is ...
Breaking Medicine News(10 mins):Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3
... is a risk factor for breast cancer development. However, ... ,These ER-alphanegative cancers are more aggressive and ... and have been thought to be estrogen independent. ... in advance of publication in the August print issue ...
... of the most renowned church leaders in Lesotho have signed ... the country, the UN Action Against AIDS (UNAIDS) said ... tragic toll of the AIDS epidemic, brings compelling urgency to ... achieve Universal Access for all to HIV prevention, treatment, care ...
... research has found that turning cancer cells into mini ... efficient. ,Researchers from the University of New ... Albuquerque have found that these nanoparticles could make biopsies ... need to repeat these invasive tests. ...
... that surrounds the axons of nerve cells is attacked by ... nerve impulses and, ultimately, axon loss . ,Myelin ... sheath and when used as an antigen will induce experimental ... animal model of human MS. ,Interestingly, myelin-specific T ...
... has developed a drug that is more effective in ... . ,The drug also costs less than ... reported The Himalayan Times daily.Doctors at the Patan Hospital ... ,,The team compared the effectiveness of "Cefixime", ...
... is back to the levels of 20 years ago is ... it once was and homosexuals are consequently less afraid of ... in Melbourne in which a 48-year-old was charged with deliberately ... that something more nefarious is at work. ,,The Age ...
Cached Medicine News:Health News:Senior Church Leaders in Lesotho Pledge to Fight AIDS 2Health News:New Nano-power Could Make Biopsies Sensitive and Efficient 2Health News:Autoimmune Response in Multiple Sclerosis 2
(Date:7/1/2015)... 2015  AVACEN, Inc. announced today the issue by the ... medical technology platform supporting its unique Dry Heat Therapy AVACEN ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... 9,066,781 - Methods And Apparatus For Therapeutic Application of Thermal ... methods of use, referred to by the company as the ...
(Date:7/1/2015)... 1, 2015 Radiant Insights announce ... Oxygen Concentrators Market Shares, Strategy, and Forecasts, Worldwide, ... continuing growth as the aging population worldwide needs homecare ... conditions where oxygen is able to improve the quality ... have become affordable and support a mobile lifestyle even ...
(Date:7/1/2015)... , July 1, 2015 ... is expected to reach USD 49,119.2 million by 2020, ... Inc. Monitoring services is expected to remain the dominant ... USD 1,227.5 million in 2012, and an estimated CAGR ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse full ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5
... following statement,by Andrea Kavanagh, Director of the Pure Salmon ... publish a study tomorrow that,shows sea lice from open ... wild fish stocks., "This study confirms what we ... havoc on wild salmon populations. If outbreaks of these,parasites ...
... Results, SOUTH SAN FRANCICSO, Calif., Dec. 13 ... announced that its oral syk,kinase inhibitor, R788 (tamatinib ... Arthritis (RA) patients in a,recently completed Phase 2 ... 150mg po bid (orally, twice daily), showed higher ...
Cached Medicine Technology:Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 2Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 3Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 4Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 5Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 6
... an OraSure HIV-1 Oral Specimen Collection Device is ... for HIV-1 antibodies. Testing with the OraSure HIV-1 ... needles and has been shown to be more ... specially treated cotton fiber pad attached to a ...
... benefits of TiMAX material have been applied to ... strength and an ultra-low profile combine to provide ... lower extremity. , ,This complete set of periarticular ... , Fibula Composite Plate , ...
The DePuy ACE Titanium Active Compression Plate offers ingenuity in the art of fracture management....
Corneal Marking Pen - Sterile. 10 pieces/box...
Medicine Products: